Exosomal miR92a Promotes Cytarabine Resistance in Myelodysplastic Syndromes by Activating Wnt/β-catenin Signal Pathway

Cytarabine (Ara-C) has been one of the frontline therapies for clonal hematopoietic stem cell disorders, such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), but Ara-C resistance often occurs and leads to treatment failure. Exosomal microRNAs (miRNAs, miRs) as small noncoding RNA...

Full description

Bibliographic Details
Published in:	Biomolecules
Main Authors:	Hongjiao Li, Chenglian Xie, Yurong Lu, Kaijing Chang, Feng Guan, Xiang Li
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Subjects:	MDS/AML exosomal miR92a Ara-C resistance PTEN Wnt/β-catenin
Online Access:	https://www.mdpi.com/2218-273X/12/10/1448

Similar Items

Acute myeloid leukemia cells and MSC-derived exosomes inhibiting transformation in myelodysplastic syndrome
by: Xiaoli Liu, et al.
Published: (2023-06-01)

LncRNA GAS5 Competitively Combined With miR-21 Regulates PTEN and Influences EMT of Peritoneal Mesothelial Cells via Wnt/β-Catenin Signaling Pathway
by: Yi Fan, et al.
Published: (2021-08-01)

VGLL4 regulates the Wnt/β-catenin signaling pathway and acts as an oncogenic factor in acute myeloid leukemia
by: Chen Zhou, et al.
Published: (2026-12-01)

The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/β-catenin signaling
by: Alexander R. Marr, et al.
Published: (2024-03-01)

Activation of the Wnt/β-catenin signalling pathway enhances exosome production by hucMSCs and improves their capability to promote diabetic wound healing
by: Liming Wang, et al.
Published: (2024-06-01)

Immune checkpoint gene VSIR predicts patient prognosis in acute myeloid leukemia and myelodysplastic syndromes
by: Kevin Yao, et al.
Published: (2023-03-01)

MEG3 targets miR-184 and Wnt/β-catenin and modulates properties of osteosarcoma
by: Liang Li, et al.
Published: (2020-06-01)

Cigarette Smoke-Induced Gastric Cancer Cell Exosomes Affected the Fate of Surrounding Normal Cells via the Circ0000670/Wnt/β-Catenin Axis
by: Zhaofeng Liang, et al.
Published: (2023-05-01)

Exosomal miR-92a-3p serves as a promising marker and potential therapeutic target for adenomyosis
by: Wanqi Shao, et al.
Published: (2025-03-01)

TMEM88 Modulates Lipid Synthesis and Metabolism Cytokine by Regulating Wnt/β-Catenin Signaling Pathway in Non-Alcoholic Fatty Liver Disease
by: Huan Zhou, et al.
Published: (2022-01-01)

CLINICAL AND CYTOGENETIC PROFILE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME
by: Muneshwar Kumar, et al.
Published: (2019-06-01)

Hypoxic BMSC-derived exosomal miR-210-3p promotes progression of triple-negative breast cancer cells via NFIX-Wnt/β-catenin signaling axis
by: Meng Wang, et al.
Published: (2025-01-01)

miR-92a promotes proliferation and inhibits apoptosis of prostate cancer cells through the PTEN/Akt signaling pathway
by: Zheng Yanshen, et al.
Published: (2021-01-01)

Microglial exosome TREM2 ameliorates ferroptosis and neuroinflammation in alzheimer’s disease by activating the Wnt/β-catenin signaling
by: Ling Zhu, et al.
Published: (2025-07-01)

LRRFIP1 enhances the Wnt/β-catenin pathway by binding to DVLs in myelodysplastic syndrome
by: Xiaoli Zhao, et al.
Published: (2025-05-01)

PTEN inhibits epithelial mesenchymal transition of thyroid cancer cells by regulating the Wnt/β-Catenin signaling pathway
by: Li Wei, et al.
Published: (2024-12-01)

Fixed-time treatment of elderly patients with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) using hypomethylating agents and venetoclax – a case series
by: Albrecht Lindemann, et al.
Published: (2026-05-01)

Targeting CD47/SIRPα in Acute Myeloid Leukemia and Myelodysplastic Syndrome: Preclinical and Clinical Developments of Magrolimab
by: Fadi Haddad, et al.
Published: (2021-05-01)

Case report: Dynamic genetic profiles reveal a patient with myelodysplastic neoplasm transforming into acute myeloid leukemia
by: Guiying Guo, et al.
Published: (2026-03-01)

Exosomes derived from miR-92a-3p-overexpressing human mesenchymal stem cells enhance chondrogenesis and suppress cartilage degradation via targeting WNT5A
by: Guping Mao, et al.
Published: (2018-09-01)

Dedifferentiated fat cells-derived exosomes (DFATs-Exos) loaded in GelMA accelerated diabetic wound healing through Wnt/β-catenin pathway
by: Miao Dong, et al.
Published: (2025-02-01)

Influence of different therapy strategies in patients with myelodysplastic neoplasms (MDS) on overall survival with regard to different decades: data from the German MDS registry
by: Jonas Welsch, et al.
Published: (2026-04-01)

Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway
by: Hui Cheng, et al.
Published: (2023-08-01)

Overview of Wnt/β-Catenin Pathway and DNA Damage/Repair in Cancer
by: Silvina B. Nadin, et al.
Published: (2025-02-01)

The Role of Inhibition of Apoptosis in Acute Leukemias and Myelodysplastic Syndrome
by: Amanda McBride, et al.
Published: (2019-03-01)

hsa_circ_0000285 sponging miR-582-3p promotes neuroblastoma progression by regulating the Wnt/β-catenin signaling pathway
by: Du Jun, et al.
Published: (2023-07-01)

Exosomes derived from platelet-rich plasma present a novel potential in alleviating knee osteoarthritis by promoting proliferation and inhibiting apoptosis of chondrocyte via Wnt/β-catenin signaling pathway
by: Xuchang Liu, et al.
Published: (2019-12-01)

The miR-34/449 clusters regulate the differentiation of ciliated cells in the oviduct via the Wnt/β-catenin signaling pathway
by: Qiqian Wu, et al.
Published: (2025-10-01)

miR-340 reverses chemotherapy resistance in colon cancer via the PDCD4/WNT/β-catenin signalling pathway
by: Hanbing Xu, et al.
Published: (2025-09-01)

Targeting Wnt/β-catenin activation in combination with temozolomide leads to glioblastoma inhibition and long-term survival in mice
by: Xiaowei Zhang, et al.
Published: (2026-01-01)

Rotavirus-Mediated Suppression of miRNA-192 Family and miRNA-181a Activates Wnt/β-Catenin Signaling Pathway: An In Vitro Study
by: Anwesha Banerjee, et al.
Published: (2022-03-01)

HAPLOIDENTICAL TRANSPLANT WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROMES PATIENTS: THE ROLE OF PREVIOUS LINES OF THERAPY.
by: Daniele Avenoso, et al.
Published: (2024-01-01)

Relationship between Wnt/β-catenin signaling pathway and lupus nephritis
by: MA Xiao, et al.
Published: (2018-01-01)

Potential of peptide‐engineered exosomes with overexpressed miR‐92b‐3p in anti‐angiogenic therapy of ovarian cancer
by: Jiaying Wang, et al.
Published: (2021-05-01)

Wnt and β-Catenin Signaling in the Bone Metastasis of Prostate Cancer
by: Zachary Kaplan, et al.
Published: (2021-10-01)

Wnt1 and β-Catenin Expression in Lobular Capillary Hemangioma: Immunohistochemical Study
by: Esma İnan Yüksel, et al.
Published: (2023-08-01)

Mutation spectrum, expression profiling, and prognosis evaluation of Fanconi anemia signaling pathway genes for 4259 patients with myelodysplastic syndromes or acute myeloid leukemia
by: Lixian Chang, et al.
Published: (2023-11-01)

Andrographolide Exerts Pro-Osteogenic Effect by Activation of Wnt/β-Catenin Signaling Pathway in Vitro
by: Tongmeng Jiang, et al.
Published: (2015-07-01)

Hyperin Controls the Development and Therapy of Gastric Cancer via Regulating Wnt/β-Catenin Signaling
by: Ping MH
Published: (2020-11-01)

The recent progress of peptide regulators for the Wnt/β-catenin signaling pathway
by: Nan Zhang, et al.
Published: (2023-06-01)